These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38733492)

  • 1. A small molecule compound 759 inhibits the wnt/beta-catenin signaling pathway via increasing the Axin protein stability.
    Sun S; Gong YD; Kang JS; Dong MS; Choi Y
    Med Oncol; 2024 May; 41(6):147. PubMed ID: 38733492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zbed3 promotes proliferation and invasion of lung cancer partly through regulating the function of Axin-Gsk3β complex.
    Shi X; Zhao Y; Fan C
    J Cell Mol Med; 2019 Feb; 23(2):1014-1021. PubMed ID: 30417576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Discovery and Characterization of K-756, a Novel Wnt/β-Catenin Pathway Inhibitor Targeting Tankyrase.
    Okada-Iwasaki R; Takahashi Y; Watanabe Y; Ishida H; Saito J; Nakai R; Asai A
    Mol Cancer Ther; 2016 Jul; 15(7):1525-34. PubMed ID: 27196752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Anti-Tumor Activity of Succinyl Macrolactin A Is Mediated through the β-Catenin Destruction Complex via the Suppression of Tankyrase and PI3K/Akt.
    Regmi SC; Park SY; Kim SJ; Banskota S; Shah S; Kim DH; Kim JA
    PLoS One; 2015; 10(11):e0141753. PubMed ID: 26544726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the NAD
    Ye C; Qi L; Li X; Wang J; Yu J; Zhou B; Guo C; Chen J; Zheng S
    Cell Commun Signal; 2020 Jan; 18(1):16. PubMed ID: 32005247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of microRNA-31-5p inhibits proliferation and invasion of osteosarcoma cells through Wnt/β-catenin signaling pathway by enhancing AXIN1.
    Chen X; Zhong L; Li X; Liu W; Zhao Y; Li J
    Exp Mol Pathol; 2019 Jun; 108():32-41. PubMed ID: 30844369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAP-dependent ubiquitination and degradation of β-catenin mediates inhibition of Wnt signalling induced by Physalin F in colorectal cancer.
    Chen C; Zhu D; Zhang H; Han C; Xue G; Zhu T; Luo J; Kong L
    Cell Death Dis; 2018 May; 9(6):591. PubMed ID: 29789528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilizing and upregulating Axin with tankyrase inhibitor reverses 5-fluorouracil chemoresistance and proliferation by targeting the WNT/caveolin-1 axis in colorectal cancer cells.
    Luo F; Li J; Liu J; Liu K
    Cancer Gene Ther; 2022 Nov; 29(11):1707-1719. PubMed ID: 35750753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling.
    Tong Y; Liu Y; Zheng H; Zheng L; Liu W; Wu J; Ou R; Zhang G; Li F; Hu M; Liu Z; Lu L
    Oncotarget; 2016 May; 7(21):31413-28. PubMed ID: 27119499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for tankyrases as antineoplastic targets in lung cancer.
    Busch AM; Johnson KC; Stan RV; Sanglikar A; Ahmed Y; Dmitrovsky E; Freemantle SJ
    BMC Cancer; 2013 Apr; 13():211. PubMed ID: 23621985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt/β-catenin signaling pathway is involved in regulating the migration by an effective natural compound brucine in LoVo cells.
    Shi X; Zhu M; Kang Y; Yang T; Chen X; Zhang Y
    Phytomedicine; 2018 Jul; 46():85-92. PubMed ID: 30097126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization, and evaluation of a novel inhibitor of WNT/β-catenin signaling pathway.
    Yan Z; Zhu Z; Wang J; Sun J; Chen Y; Yang G; Chen W; Deng Y
    Mol Cancer; 2013 Oct; 12(1):116. PubMed ID: 24098916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
    Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
    Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-molecule binding of the axin RGS domain promotes β-catenin and Ras degradation.
    Cha PH; Cho YH; Lee SK; Lee J; Jeong WJ; Moon BS; Yun JH; Yang JS; Choi S; Yoon J; Kim HY; Kim MY; Kaduwal S; Lee W; Min do S; Kim H; Han G; Choi KY
    Nat Chem Biol; 2016 Aug; 12(8):593-600. PubMed ID: 27294323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.
    Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J
    Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gαi2-induced conductin/axin2 condensates inhibit Wnt/β-catenin signaling and suppress cancer growth.
    Miete C; Solis GP; Koval A; Brückner M; Katanaev VL; Behrens J; Bernkopf DB
    Nat Commun; 2022 Feb; 13(1):674. PubMed ID: 35115535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Synthetic Small Molecule FL3 Combats Intestinal Tumorigenesis via Axin1-Mediated Inhibition of Wnt/β-Catenin Signaling.
    Jackson DN; Alula KM; Delgado-Deida Y; Tabti R; Turner K; Wang X; Venuprasad K; Souza RF; Désaubry L; Theiss AL
    Cancer Res; 2020 Sep; 80(17):3519-3529. PubMed ID: 32665357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling.
    Yamada K; Hori Y; Inoue S; Yamamoto Y; Iso K; Kamiyama H; Yamaguchi A; Kimura T; Uesugi M; Ito J; Matsuki M; Nakamoto K; Harada H; Yoneda N; Takemura A; Kushida I; Wakayama N; Kubara K; Kato Y; Semba T; Yokoi A; Matsukura M; Odagami T; Iwata M; Tsuruoka A; Uenaka T; Matsui J; Matsushima T; Nomoto K; Kouji H; Owa T; Funahashi Y; Ozawa Y
    Cancer Res; 2021 Feb; 81(4):1052-1062. PubMed ID: 33408116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor activity of three ginsenoside derivatives in lung cancer is associated with Wnt/β-catenin signaling inhibition.
    Bi X; Xia X; Mou T; Jiang B; Fan D; Wang P; Liu Y; Hou Y; Zhao Y
    Eur J Pharmacol; 2014 Nov; 742():145-52. PubMed ID: 25199964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.